Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin

Journal of Internal Medicine

Volumn 231, Issue 6, 1992, Pages 601-606

  LINDE, T ^a   SANDHAGEN, B ^a   DANIELSON, B G ^a   WIKSTROM B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

blood viscosity; erythrocyte deformability; erythropoietin; hypertension; renal anaemia; uraemia

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD VISCOSITY; CLINICAL ARTICLE; FEMALE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SEIZURE; SUBCUTANEOUS DRUG ADMINISTRATION; UREMIA;

EID: 0026769196     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.1992.tb01246.x     Document Type: Article

References (28)

1. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic hemodialysis
2. Correction of the anaemia of end‐stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial
3. Treatment of renal anaemia with recombinant human erythropoietin
4. Effect of erythropoietin administration on blood and plasma viscosity in hemodialysis patients
5. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin
6. Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: implications of erythropoietin therapy
7. The viscosity of the blood in narrow capillary tubes
8. In vivo measurements of ‘apparent viscosity’ and microvessel hematocrit in the mesentery of the cat
9. Haemorheological study of patients with chronic renal failure being submitted to chronic haemodialysis
10. Study of the hemorheological parameters in patients with chronic renal failure and effects of the treatment by dialysis
11. Hemorheological abnormalities in chronic renal failure patients
12. Macro‐ and microrheological determinants in chronic renal failure
13. Analysis of haemorheological variables—methodology and reference values
14. A method for the computation of age‐dependent reference intervals
15. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin
16. Red cell deformability and its relevance to blood flow
17. Effect of isradipine on factors affecting blood viscosity
18. Increased whole blood viscosity combined with decreased erythrocyte fluidity in untreated patients with essential hypertension
19. Decreased deformability of erythrocytes and increased intracellular calcium in patients with chronic renal failure
20. Erythropoietin stimulates a rise in intracellular free calcium concentration in single early human erythroid precursors
21. Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link?
22. Action of rHuEpo on mechanical membrane properties of red blood cells in children with end‐stage renal disease
23. The effect of human recombinant erythropoietin on erythrocyte deformability in uremic children
24. Mean red cell life of rats exposed to reduced barometric pressure
25. Humoral regulation of erythropoiesis. VII. Shortened survival of erythrocytes produced by erythropoietin or severe anemia
26. Studies on erythrokinetics in infancy. XIII. The mean life span and the life span frequency function of red blood cells formed during foetal life
27. Characterization of the anaemia of chronic renal failure and the mode of its correction by a preparation of human erythropoietin (r‐HuEPO). An investigation of the pharmacokinetics of intravenous erythropoietin and its effects on erythrokinetics
28. Seizures and hypertension events